8-K 1 0001.txt FORM 8-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 5, 2000 PATHOGENESIS CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-27150 91-1542150 (State or other (Commission (IRS Employer jurisdiction of File No.) Identification No.) incorporation) 201 Elliott Avenue West, Seattle, Washington 98119 (Address of principal executive offices) (206) 467-8100 (Registrant's telephone number, including area code) Not applicable (Former name or former address, if changes since last report) Item 5. Other Events Annexed hereto as Exhibit 1 is a copy of a press release issued by PathoGenesis Corporation on June 5, 2000 announcing that PathoGenesis has engaged advisers to assist in PathoGenesis' efforts to explore strategic alternatives for enhancing shareholder value. Item 7. Exhibits Exhibit Number Description 1 Press Release dated June 5, 2000 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: June 5, 2000 PATHOGENESIS CORPORATION By: /s/ Alan R. Meyer --------------------------------------- Alan R. Meyer Executive Vice President and Chief Financial Officer 3